EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patientsAccess, Myeloma, News20 November 2024
MPE comments on the European Medicines Agency’s policy on the handling of competing interests of scientific committees’ members and expertsMPE, News14 November 2024
MPE comments on the Implementing Regulation on joint scientific consultations on medicinal products for human use at Union levelAccess, News29 October 2024
A second bispecific antibody is approved as a fourth-line treatment for myeloma in England and WalesAccess, Myeloma, News17 July 2024
